March 14, 2018 / 10:20 AM / in 6 months

BRIEF-Tetra Bio-Pharma Announces FDA Orphan Drug Designation For PPP001 In Treatment Of Complex Regional Pain Syndrome

March 14 (Reuters) - Tetra Bio Pharma Inc:

* TETRA BIO-PHARMA ANNOUNCES FDA ORPHAN DRUG DESIGNATION FOR PPP001 IN TREATMENT OF COMPLEX REGIONAL PAIN SYNDROME

* TETRA BIO-PHARMA ANNOUNCES FDA ORPHAN DRUG DESIGNATION FOR PPP001 IN TREATMENT OF COMPLEX REGIONAL PAIN SYNDROME

* TETRA BIO PHARMA INC - ORPHAN DRUG DESIGNATION WAS GRANTED FOR ACTIVE MOIETY OF DRUG PPP001 AND NOT FORMULATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below